Profile data is unavailable for this security.
About the company
Jacobson Pharma Corporation Ltd is an investment holding company principally engaged in the manufacturing and sale of generic drugs. The Company operates its business through two segments. The Generic Drugs segment is engaged in the development, manufacture and distribution of a host of off-patent medicines for various therapeutic use. The Branded Healthcare segment is engaged in the development, manufactures and distributes branded medicines, proprietary Chinese medicines and health and wellness products. Currently the activities of two segments in this regard are primarily carried out in Hong Kong.
- Revenue in HKD (TTM)1.68bn
- Net income in HKD212.16m
- Incorporated--
- Employees1.59k
- LocationJacobson Pharma Corporation LtdUnit 2313-18, 23/F,Tower 1, Millennium2681 Hong KongHKG
- Phone+852 22672298
- Websitehttp://www.jacobsonpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JW (Cayman) Therapeutics Co Ltd | 188.01m | -830.51m | 712.70m | 398.00 | -- | 0.3895 | -- | 3.79 | -2.02 | -2.02 | 0.4569 | 4.42 | 0.0704 | 1.88 | 65.54 | 472,380.00 | -31.11 | -39.77 | -35.21 | -44.00 | 50.74 | -- | -441.74 | -1,316.81 | 3.90 | -11.83 | 0.1592 | -- | 19.32 | -- | 9.23 | -- | -- | -- |
| Brii Biosciences Ltd | 667.22k | -189.06m | 729.64m | 128.00 | -- | 0.2163 | -- | 1,093.55 | -0.2599 | -0.2599 | 0.0009 | 4.62 | 0.0002 | -- | -- | 5,212.67 | -5.60 | -- | -5.84 | -- | -- | -- | -29,881.69 | -- | -- | -- | 0.001 | -- | -98.80 | -- | 63.90 | -- | -- | -- |
| Jbm (Healthcare) Ltd | 610.30m | 97.99m | 734.06m | 258.00 | 8.10 | 0.7824 | 4.93 | 1.20 | 0.1087 | 0.1087 | 0.6786 | 1.12 | 0.4406 | 5.88 | 4.10 | 2,000,994.00 | 7.56 | 3.33 | 9.04 | 4.93 | 47.70 | 45.97 | 17.17 | 10.97 | 1.45 | 22.15 | 0.1211 | 13.81 | 28.11 | 14.51 | 131.90 | 6.14 | -5.09 | -- |
| Transcenta Holding Limited | 58.23m | -500.22m | 763.66m | 215.00 | -- | 0.6853 | -- | 13.11 | -1.23 | -1.23 | 0.1431 | 2.55 | 0.0281 | 2.05 | 1.49 | 270,847.00 | -24.17 | -- | -33.97 | -- | 26.74 | -- | -859.01 | -- | 1.20 | -32.87 | 0.285 | -- | -47.15 | -- | -13.72 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 20.28m | -416.38m | 851.98m | 313.00 | -- | 0.3846 | -- | 42.02 | -0.7655 | -0.7655 | 0.0373 | 4.06 | 0.0075 | -- | 0.3433 | 64,780.13 | -15.43 | -- | -17.27 | -- | 75.98 | -- | -2,053.54 | -- | 5.32 | -47.54 | 0.1041 | -- | -- | -- | 5.47 | -- | -- | -- |
| Hbm Holdings Ltd | 701.20m | 178.60m | 862.56m | 154.00 | 4.48 | 0.9155 | 4.02 | 1.23 | 0.2498 | 0.2498 | 0.9707 | 1.22 | 0.3886 | 3.90 | 3.01 | 4,553,269.00 | 9.88 | -54.61 | 14.13 | -66.04 | 97.73 | 97.81 | 25.43 | -400.28 | 3.28 | 6.98 | 0.3556 | -- | 120.13 | 127.06 | 116.61 | -- | -- | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 910.04m | 160.27m | 1.02bn | 848.00 | 6.36 | 0.6369 | 8.31 | 1.12 | 0.2861 | 0.2861 | 1.62 | 2.86 | 0.3587 | 2.18 | 2.94 | 1,073,165.00 | 6.32 | 7.67 | 9.12 | 10.48 | 69.40 | 78.79 | 17.61 | 20.68 | 1.51 | -- | 0.0515 | 7.22 | -0.0049 | 5.38 | -23.43 | -1.67 | -1.14 | -- |
| VIVA Biotech Holdings | 2.33bn | -125.56m | 1.03bn | 2.08k | -- | 0.2551 | 8.49 | 0.4404 | -0.0639 | -0.0639 | 1.20 | 1.86 | 0.2805 | 4.84 | 5.13 | 1,122,308.00 | -1.30 | -1.39 | -1.79 | -1.68 | 34.26 | 34.81 | -4.63 | -5.44 | 1.15 | 0.035 | 0.3412 | -- | -9.42 | 59.31 | 78.03 | -- | -- | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.22bn | 176.02m | 1.05bn | 2.64k | 5.87 | 0.9292 | 3.66 | 0.4753 | 0.2078 | 0.2078 | 2.62 | 1.31 | 1.12 | 2.53 | 10.54 | 838,690.60 | 8.95 | 7.69 | 14.15 | 11.75 | 59.73 | 60.56 | 8.01 | 6.73 | 0.894 | -- | 0.1424 | 42.46 | 12.26 | 12.41 | 53.00 | 13.86 | 17.65 | 3.22 |
| Jacobson Pharma Corporation Ltd | 1.68bn | 212.16m | 1.14bn | 1.59k | 5.12 | 0.4779 | 2.88 | 0.6774 | 0.1112 | 0.1409 | 0.8822 | 1.19 | 0.3722 | 2.87 | 7.50 | 940,829.50 | 5.16 | 4.91 | 6.61 | 6.60 | 42.05 | 41.81 | 13.85 | 14.32 | 1.01 | 5.62 | 0.3646 | 35.97 | 11.91 | 2.89 | 41.30 | 4.42 | -6.22 | 6.39 |
| TOT Biopharm International Co Ltd | 844.17m | -40.83m | 1.17bn | 463.00 | -- | 1.57 | 307.52 | 1.38 | -0.0563 | -0.0563 | 1.16 | 0.9609 | 0.5808 | 1.87 | 7.75 | -- | -2.81 | -20.01 | -3.72 | -25.21 | 73.53 | 74.74 | -4.84 | -68.53 | 1.48 | -4.60 | 0.3348 | -- | 76.54 | 81.88 | 24.36 | -- | -- | -- |
| CStone Pharmaceuticals | 501.60m | -397.13m | 1.18bn | 230.00 | -- | 2.39 | -- | 2.36 | -0.3148 | -0.3148 | 0.3971 | 0.3847 | 0.2811 | 2.44 | 3.72 | 2,180,857.00 | -22.25 | -54.76 | -48.85 | -81.68 | 65.60 | -- | -79.17 | -301.62 | 1.44 | -- | 0.4431 | -- | -3.64 | -- | 59.32 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 68.69m | -388.35m | 1.20bn | 301.00 | -- | 1.04 | -- | 17.52 | -0.5024 | -0.5024 | 0.0889 | 1.47 | 0.0419 | -- | 5.21 | 228,207.00 | -23.66 | -45.76 | -26.86 | -49.30 | 5.04 | -- | -565.36 | -372.22 | -- | -- | 0.1636 | -- | -33.66 | -- | 3.43 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.71bn | 275.26m | 1.24bn | 1.48k | 4.65 | 0.6432 | 3.70 | 0.725 | 0.4689 | 0.4689 | 2.87 | 3.39 | 0.6161 | 2.28 | 3.35 | 1,152,300.00 | 9.94 | 11.20 | 13.21 | 14.73 | 90.20 | 86.01 | 16.13 | 19.77 | 1.46 | -- | 0.1326 | 16.16 | 29.51 | 7.72 | 22.11 | 3.56 | 7.29 | 7.39 |
| Ascletis Pharma Inc | 61.20m | -156.49m | 1.33bn | 219.00 | -- | 0.5549 | -- | 21.68 | -0.1471 | -0.1471 | 0.057 | 2.36 | 0.022 | 2.30 | 3.86 | 279,464.40 | -5.62 | -6.43 | -5.91 | -6.64 | 45.92 | 35.67 | -255.70 | -243.38 | 16.54 | -6.09 | 0.0036 | -- | 4.63 | -19.39 | 54.04 | -- | -- | -- |
| Wuhan YZY Biopharma Co Ltd | -100.00bn | -100.00bn | 1.44bn | 123.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -1.50 | -- | -- | -- |
Data as of Apr 25 2024. Currency figures normalised to Jacobson Pharma Corporation Ltd's reporting currency: Hong Kong Dollar HKD
0.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 04 Apr 2024 | 4.71m | 0.24% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 628.04k | 0.03% |
| Bessemer Investment Management LLCas of 31 Jan 2024 | 205.92k | 0.01% |
| Lazard Asset Management LLCas of 31 Mar 2024 | 126.00k | 0.01% |
| DFA Australia Ltd.as of 31 May 2023 | 65.24k | 0.00% |
| Nomura Asset Management Co., Ltd.as of 29 Mar 2024 | 5.23k | 0.00% |
More ▼
Data from 31 Dec 2023 - 18 Apr 2024Source: FactSet Research Systems Inc.
